Oligodendroglioma: all 225 studies
Page 2 of 3. Open to participants first (31), then studies with results posted, then the rest; newest registration first within each.
- Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant GliomasCompletedNCT05393258Not applicable
- A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine GliomaActive, not recruitingNCT04978727Phase 1
- Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed ModelsStatus unknownNCT04970615
- Proteomic Characterization of Aggressive OligodendrogliomasStatus unknownNCT04843085
- Primary Chemotherapy by BCNU-TMZ Combination in Newly Diagnosed Anaplastic Oligodendrocytic Tumors: Phase II Trial With Translational Molecular AnalysisCompletedNCT04755023Phase 2
- Long Term Implications of Rare Brain Tumours'CompletedNCT04708548
- Radiotherapy in IDH Mutated Glioma: Evaluation of Late OutcomesCompletedNCT04304300
- Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed GlioblastomaWithdrawnNCT04105374Phase 2/3
- Pediatric Long-Term Follow-up and Rollover StudyActive, not recruitingNCT03975829Phase 4
- Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade GliomasTerminatedNCT03971734Phase 1
- Social Determinants of Health in Glioblastoma PopulationCompletedNCT03900689
- The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Status unknownNCT03896958
- Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain MetastasesTerminatedNCT03796273Early Phase 1
- Investigation of Oral OKN-007 in Recurrent High-grade Glioma ParticipantsWithdrawnNCT03649464Phase 1/2
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk OligodendrogliomaWithdrawnNCT03353896Not applicable
- Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain TumorsActive, not recruitingNCT03220646Phase 2
- Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III GliomaActive, not recruitingNCT03180502Phase 2
- A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2Active, not recruitingNCT03152318Phase 1
- Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent GlioblastomaWithdrawnNCT03014804Phase 2
- Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade GliomasWithdrawnNCT02976441Early Phase 1
- Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesTerminatedNCT02967380Not applicable
- Neural Basis of Language ProcessingCompletedNCT02903784Not applicable
- RRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic GliomasCompletedNCT02871843Phase 1
- Expanded Access to ANG1005 for Individual PatientsNo longer availableNCT02755987
- Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain TumorsCompletedNCT02747407
- Clinical Development of MR Spectroscopy and Imaging in Brain CancersCompletedNCT02731521
- Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain TumorsCompletedNCT02644291Phase 1
- Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II GliomaCompletedNCT02549833Phase 1
- Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain TumorsCompletedNCT02444546Phase 1
- Clinical Development of Cancer-Specific MRS Biomarkers in Malignant GliomasCompletedNCT02388659
- A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsActive, not recruitingNCT02381886Phase 1
- Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant GliomasCompletedNCT02238496Phase 1
- A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade GliomasStatus unknownNCT02209428Phase 2
- Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsWithdrawnNCT02194452Not applicable
- Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade GliomaCompletedNCT02101905Phase 1
- Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade GliomasWithdrawnNCT02055196Phase 1
- Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By SurgeryTerminatedNCT02031965Phase 1
- 3T MRI Biomarkers of Glioma Treatment ResponseTerminatedNCT01996527Early Phase 1
- Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain TumorCompletedNCT01985256Phase 1
- p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System TumorsCompletedNCT01975116Phase 1
- Evaluating the Expression Levels of MicroRNA-10b in Patients With GliomasTerminatedNCT01849952
- Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II TrialCompletedNCT01847235Phase 2
- Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant GliomaStatus unknownNCT01656980Phase 3
- Carboplatin in Treating Patients With Recurrent High-Grade GliomasCompletedNCT01644955Phase 1
- Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant GliomaStatus unknownNCT01637753Not applicable
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
- Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain TumorCompletedNCT01470794Phase 1
- Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone SurgeryCompletedNCT01417507
- Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant GliomaCompletedNCT01392209Phase 1
- High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent GliomaTerminatedNCT01378481Phase 1
- Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade GliomaTerminatedNCT01339039Phase 1
- AZD8055 for Adults With Recurrent GliomasCompletedNCT01316809Phase 1
- (11C)dLop as a Marker of P-Glycoprotein Function in Patients With GliomasTerminatedNCT01281982
- RO4929097 in Treating Patients With Recurrent Invasive GliomasTerminatedNCT01269411Phase 1
- Vaccine Therapy and Sargramostim in Treating Patients With Malignant GliomaCompletedNCT01250470Phase 1
- Yoga Therapy in Treating Patients With Malignant Brain TumorsTerminatedNCT01234805Not applicable
- Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain MetastasesCompletedNCT01234740Phase 1
- Dendritic Cell Vaccine for Patients With Brain TumorsCompletedNCT01204684Phase 2
- A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade GliomasCompletedNCT01172964Phase 1
- Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant GliomaCompletedNCT01165632Early Phase 1
- A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant GliomaCompletedNCT01156584Phase 1
- Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain TumorsTerminatedNCT01148966Phase 1
- Cellular Immunotherapy Study for Brain CancerCompletedNCT01144247Phase 1
- Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1
- RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaCompletedNCT01119599Phase 1
- Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant GliomaTerminatedNCT01103375Phase 1
- FET-PET for Diagnosis and Monitoring in Patients With Low Grade GliomaStatus unknownNCT01089244
- Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 1
- Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2CompletedNCT01082926Phase 1
- Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord TumorsCompletedNCT01076530Phase 1
- Proton Beam Radiation Therapy in Treating Patients With Low Grade GliomasCompletedNCT01024907Phase 1/2
- Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and LymphomaCompletedNCT00994500Phase 1
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade GliomaActive, not recruitingNCT00978458Phase 3
- ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS TumorsCompletedNCT00946335Phase 1
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain TumorsCompletedNCT00919750
- Treatment Strategy for Low-grade GliomasTerminatedNCT00897377Phase 3
- Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade GliomaActive, not recruitingNCT00887146Phase 3
- Sorafenib in Newly Diagnosed High Grade GliomaCompletedNCT00884416Phase 1
- HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II GliomasCompletedNCT00874861Early Phase 1
- Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-AstrocytomasCompletedNCT00795457Early Phase 1
- Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant GliomaWithdrawnNCT00734864Phase 1
- A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade GliomasCompletedNCT00734682Phase 1
- Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant GliomaCompletedNCT00730613Phase 1
- Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or TemozolomideCompletedNCT00717210Phase 3
- A Study of 131I-TM601 in Adults With Recurrent Malignant GliomaStatus unknownNCT00683761Phase 1/2
- Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant GliomaCompletedNCT00650923Phase 1
- Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.WithdrawnNCT00645385
- Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant GliomaStatus unknownNCT00591058Phase 1
- Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant GliomaTerminatedNCT00430079Not applicable
- Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed OligoastrocytomaCompletedNCT00400816Phase 2
- A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic GliomaTerminatedNCT00389090Phase 2
- Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed OligoastrocytomaCompletedNCT00362570Phase 2
- AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS TumorsCompletedNCT00326664Phase 1
- Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain TumorsCompletedNCT00303849Phase 1/2
- Vorinostat and Temozolomide in Treating Patients With Malignant GliomasActive, not recruitingNCT00268385Phase 1
- Photodynamic Therapy in the Treatment of Malignant Intracranial TumorsWithdrawnNCT00243490Phase 2
- Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain TumoursCompletedNCT00213876
- Prolonged Daily Temozolomide for Low-Grade GliomaCompletedNCT00165360Phase 2
- Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain TumorsTerminatedNCT00110032Phase 1